Products

What will AGI do for Anagestone acetate?

This classification denotes a therapeutic progestin with the molecular formula C24H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GNT396G9QT, chemically known as pregn-4-en-20-one, 17-hydroxy-6alpha-methyl-, acetate (8ci) but more generally known as anagestone acetate, which bears US NIH Compound Identifier 18443. European Medicines Agency schedules Anagestone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00522MIG. Most nations, for tariff and trade purposes, schedule anagestone acetate under HS 29372300 and SITC 54153. As of Q4 2014, ANAGESTONE ACETATE remains US FDA's Preferred Term for this commodity. Anagestone acetate bears US NLM identifiers UMLS ID C2698107 and NCI Concept Code C76302. SMILES: C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CCCC4)C.